Inside EE’s New Research Roadmap for the Final 10%
At Emily’s Entourage’s inaugural State of the Science: EE Edition webinar, we unveiled a bold new Research Roadmap—and shared why years of... Read More
Inside EE’s Newest Research Grants: Tackling the Barriers to CF Breakthroughs
Six newly funded projects are pursuing promising solutions to some of the field’s toughest challenges for the final 10%. Getting gene-editing... Read More
Emily’s Entourage Breaks New Ground with AI-Powered Grant to Identify Next-Generation CF Gene Therapy Delivery Systems
AI-guided lipid nanoparticle screening aims to overcome longstanding barriers to inhaled CF gene therapy Lower Merion, PA—September 9, 2026—Emily’s Entourage (EE), an... Read More
New Emily’s Entourage Grant to Fund Novel Phage-Based Therapy for Drug-Resistant Infections in Cystic Fibrosis
Inhaled bacteriophage-antibiotic combination could offer a new treatment approach for persistent, antibiotic-resistant lung infections Lower Merion, PA—September 3, 2026—Emily’s Entourage (EE), an... Read More
Emily’s Entourage Appoints David A. Waltz, MD, as First Chief Medical Officer
Veteran cystic fibrosis physician-scientist and former Vertex Pharmaceuticals senior leader to help accelerate therapies for the final 10% of people with cystic... Read More
Advancing CF Science: Emily’s Entourage Announces New 2025 Research Grants
EE Awards Research Grants to Fuel Innovation for the Final 10% Emily’s Entourage is proud to announce the 2025 recipients of our... Read More
Emily’s Entourage Awards New Funding to University of Texas at Austin to Advance Breakthrough Gene Editing Therapy for Hard-to-Treat Cystic Fibrosis Mutations
With support from Emily’s Entourage, new retron editor technology aims to restore lung function for the 10% of people with cystic fibrosis... Read More
Emily’s Entourage Awards Translational Research Grant to Accelerate Prime Editing for Hard-to-Treat Cystic Fibrosis Mutations
The newly funded project will harness high-throughput gene editing and computational modeling to develop tailored therapies for people with cystic fibrosis unable... Read More
